| Kristin Epps-martinez, APRN | |
|
312 Olson Dr, Papillion, NE 68046-2978 | |
| (402) 612-7777 | |
| Not Available |
| Full Name | Kristin Epps-martinez |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 312 Olson Dr, Papillion, Nebraska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740929843 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 2228 (Nebraska) | Primary |
| Entity Name | Community Healthcare Partners Ne Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588242929 PECOS PAC ID: 7113323197 Enrollment ID: O20210831002880 |
News Archive
Alkermes, Inc. today announced the presentation of promising preclinical results for its proprietary opioid modulator, ALKS 33, showing the drug candidate's potential in multiple disease indications.
Newborn children born with a mutation in the Plasmalemma Vesicle Associated Protein (PLVAP) gene develop severe protein losing enteropathy, according to a case study1 published in Cellular and Molecular Gastroenterology and Hepatology, the basic science journal of the American Gastroenterological Association.
BioMS Medical Corp. today reported that Spectral Diagnostics has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) for Toraymyxin(TM). Spectral Diagnostics and BioMS have entered into a services agreement whereby BioMS will assist Spectral, as required, in its commercialization of Toraymyxin(TM), a therapeutic hemoperfusion device for the treatment of severe sepsis. This approval permits Spectral to initiate its planned pivotal trial for Toraymyxin(TM) in the United States.
From the Healthcare Information and Management Systems Society (HIMSS) annual conference, Dolbey introduced DocAssist Documentation Guides to help hospitals train their physicians to document patient reports according to the upcoming ICD-10 PCS requirements.
The study shows that 8 of 11 European countries had significantly more cases after reopening, but Germany, the UAE, and Poland had fewer. In five of the eight, the cases increased, peaked, and then dropped before the reopening happened, while Romania and Serbia showed a rapid rise before reopening.
› Verified 9 days ago
| Entity Name | Midlands Family Urgent Care Lp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356896070 PECOS PAC ID: 3375998800 Enrollment ID: O20231018001472 |
News Archive
Alkermes, Inc. today announced the presentation of promising preclinical results for its proprietary opioid modulator, ALKS 33, showing the drug candidate's potential in multiple disease indications.
Newborn children born with a mutation in the Plasmalemma Vesicle Associated Protein (PLVAP) gene develop severe protein losing enteropathy, according to a case study1 published in Cellular and Molecular Gastroenterology and Hepatology, the basic science journal of the American Gastroenterological Association.
BioMS Medical Corp. today reported that Spectral Diagnostics has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) for Toraymyxin(TM). Spectral Diagnostics and BioMS have entered into a services agreement whereby BioMS will assist Spectral, as required, in its commercialization of Toraymyxin(TM), a therapeutic hemoperfusion device for the treatment of severe sepsis. This approval permits Spectral to initiate its planned pivotal trial for Toraymyxin(TM) in the United States.
From the Healthcare Information and Management Systems Society (HIMSS) annual conference, Dolbey introduced DocAssist Documentation Guides to help hospitals train their physicians to document patient reports according to the upcoming ICD-10 PCS requirements.
The study shows that 8 of 11 European countries had significantly more cases after reopening, but Germany, the UAE, and Poland had fewer. In five of the eight, the cases increased, peaked, and then dropped before the reopening happened, while Romania and Serbia showed a rapid rise before reopening.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristin Epps-martinez, APRN 302 Concord Cir, Papillion, NE 68046-4103 Ph: (402) 639-0499 | Kristin Epps-martinez, APRN 312 Olson Dr, Papillion, NE 68046-2978 Ph: (402) 612-7777 |
News Archive
Alkermes, Inc. today announced the presentation of promising preclinical results for its proprietary opioid modulator, ALKS 33, showing the drug candidate's potential in multiple disease indications.
Newborn children born with a mutation in the Plasmalemma Vesicle Associated Protein (PLVAP) gene develop severe protein losing enteropathy, according to a case study1 published in Cellular and Molecular Gastroenterology and Hepatology, the basic science journal of the American Gastroenterological Association.
BioMS Medical Corp. today reported that Spectral Diagnostics has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) for Toraymyxin(TM). Spectral Diagnostics and BioMS have entered into a services agreement whereby BioMS will assist Spectral, as required, in its commercialization of Toraymyxin(TM), a therapeutic hemoperfusion device for the treatment of severe sepsis. This approval permits Spectral to initiate its planned pivotal trial for Toraymyxin(TM) in the United States.
From the Healthcare Information and Management Systems Society (HIMSS) annual conference, Dolbey introduced DocAssist Documentation Guides to help hospitals train their physicians to document patient reports according to the upcoming ICD-10 PCS requirements.
The study shows that 8 of 11 European countries had significantly more cases after reopening, but Germany, the UAE, and Poland had fewer. In five of the eight, the cases increased, peaked, and then dropped before the reopening happened, while Romania and Serbia showed a rapid rise before reopening.
› Verified 9 days ago
Elaine Preston, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 529 Pinnacle Dr, Papillion, NE 68046 Phone: 737-787-7809 | |
Caitlin M Carlson, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 701 Pinnacle Dr Ste 105, Papillion, NE 68046 Phone: 402-505-7989 | |
Jessica Gering, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10701 S 72nd St, Ste 100, Papillion, NE 68046 Phone: 402-827-9400 Fax: 402-827-9405 | |
Mildred Pepple, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 11111 S 84th St, Papillion, NE 68046 Phone: 402-593-3131 Fax: 402-593-3117 | |
Nicole Schleisman, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 11650 S 73rd St, Papillion, NE 68046 Phone: 888-333-7520 | |
Ms. Michelle Maile Mccaslin, APRN, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 10701 S 72nd St Ste 100, Suite 100, Papillion, NE 68046 Phone: 402-827-9421 Fax: 402-999-8029 | |
Mrs. Macy Ann Laux, APRN, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 312 Olson Dr Ste 101, Papillion, NE 68046 Phone: 402-382-9117 |